Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.

PubWeight™: 7.40‹?› | Rank: Top 0.1%

🔗 View Article (PMID 32275288)

Published in JAMA Neurol on April 10, 2020

Authors

Ling Mao1, Huijuan Jin1, Mengdie Wang1, Yu Hu2, Shengcai Chen1, Quanwei He1, Jiang Chang3, Candong Hong1, Yifan Zhou1, David Wang4, Xiaoping Miao3, Yanan Li1, Bo Hu1

Author Affiliations

1: Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
2: Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
3: Department of Epidemiology and Biostatistics, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
4: Neurovascular Division, Department of Neurology, Barrow Neurological Institute, Saint Joseph's Hospital and Medical Center, Phoenix, Arizona.

Associated clinical trials:

Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study | NCT04384042

Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study | NCT04390165

Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. (PAIN-COVID) | NCT04394169

COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada | NCT04397328

Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons | NCT04401449

Smell and Taste Disorders in COVID-19 Patients (COVID-19 ORL) | NCT04427332